ABOUT

Dauntless Pharmaceuticals, Inc. develops specialty therapeutics via a one-asset, one-company model that is structured to facilitate operational efficiencies. Launched in 2015 and based in San Diego, Dauntless Pharmaceuticals has raised committed capital of $32 million from Sofinnova Ventures and Canaan Partners.